{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:02:38Z","timestamp":1784599358006,"version":"3.55.0"},"reference-count":44,"publisher":"ARAN Ediciones","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.hipert.2018.05.003","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T20:38:02Z","timestamp":1530563882000},"page":"e11-e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recomendaciones sobre el tratamiento de la hipertensi\u00f3n arterial en la prevenci\u00f3n secundaria del ictus isqu\u00e9mico"],"prefix":"10.20960","volume":"35","author":[{"given":"C.","family":"Sierra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Castilla-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Masjuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gil-Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"\u00c1lvarez-Sab\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.I.","family":"Egocheaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Armario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8588","reference":[{"key":"10.1016\/j.hipert.2018.05.003_bib0225","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11906-011-0195-x","article-title":"Vascular mechanisms in the pathogenesis of stroke","volume":"13","author":"Sierra","year":"2011","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.hipert.2018.05.003_bib0230","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.rce.2012.02.008","article-title":"Surviving a stroke: Is all quiet on the front or the great illusion?","volume":"212","author":"Sierra","year":"2012","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.hipert.2018.05.003_bib0235","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.hipert.2018.05.003_bib0240","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.hipert.2018.05.003_bib0245","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.medcli.2009.02.037","article-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica sobre prevenci\u00f3n primaria y secundaria del ictus","volume":"133","author":"Rigau Comas","year":"2009","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.hipert.2018.05.003_bib0250","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5853\/jos.2017.00164","article-title":"Blood pressure management for stroke prevention and in acute stroke","volume":"19","author":"Hong","year":"2017","journal-title":"J Stroke"},{"key":"10.1016\/j.hipert.2018.05.003_bib0255","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/STROKEAHA.115.009552","article-title":"Effect of blood pressure lowering in early ischemic stroke: Meta-analysis","volume":"46","author":"Lee","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.hipert.2018.05.003_bib0260","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.hipert.2018.05.003_bib0265","doi-asserted-by":"crossref","unstructured":"Wein T, Lindsay MP, C\u00f4t\u00e9 R, Foley N, Berlingieri J, Bhogal S, et al. Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017. Int J Stroke. 2018;13:420-43","DOI":"10.1177\/1747493017743062"},{"key":"10.1016\/j.hipert.2018.05.003_bib0270","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.hipert.2018.05.003_bib0275","first-page":"710","article-title":"Post-stroke antihypertensive treatment study. A preliminary result","volume":"108","year":"1995","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.hipert.2018.05.003_bib0280","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2018.05.003_bib0285","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/hr.2009.139","article-title":"Blood pressure reduction for the secondary prevention of stroke: A Chinese trial and a systematic review of the literature","volume":"32","author":"Liu","year":"2009","journal-title":"Hypertens Res"},{"key":"10.1016\/j.hipert.2018.05.003_bib0290","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/HYPERTENSIONAHA.116.08485","article-title":"Blood pressure reduction and secondary stroke prevention: A systematic review and metaregression analysis of randomized clinical trials","volume":"69","author":"Katsanos","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.hipert.2018.05.003_bib0295","doi-asserted-by":"crossref","first-page":"e3302","DOI":"10.1097\/MD.0000000000003302","article-title":"Comparative effectiveness of blood pressure-lowering drugs in patients who have already suffered from stroke. Traditional and bayesian network meta-analysis of randomized trials","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.hipert.2018.05.003_bib0300","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.medcli.2016.11.029","article-title":"\u00bfQu\u00e9 f\u00e1rmaco antihipertensivo deber\u00edamos utilizar en pacientes con enfermedad cerebrovascular para prevenir un nuevo ictus?","volume":"148","author":"Castilla-Guerra","year":"2017","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.hipert.2018.05.003_bib0305","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials","volume":"362","author":"Turnbull","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2018.05.003_bib0310","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.hipert.2018.05.003_bib0315","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2018.05.003_bib0320","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40256-015-0129-0","article-title":"Long-term anti-hypertensive therapy and stroke prevention. A meta-analysis","volume":"15","author":"Mukete","year":"2015","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.hipert.2018.05.003_bib0325","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: A systematic review and meta-analysis","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.hipert.2018.05.003_bib0330","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(10)60235-8","article-title":"Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: A systematic review and meta-analysis","volume":"375","author":"Webb","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2018.05.003_bib0335","first-page":"CD007890","article-title":"Beta-blockers for preventing stroke recurrence","volume":"15","author":"De Lima","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hipert.2018.05.003_bib0340","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2018.05.003_bib0345","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/STROKEAHA.111.636829","article-title":"Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: A meta-analysis of randomized controlled trials","volume":"43","author":"Sipahi","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.hipert.2018.05.003_bib0350","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/01.STR.0000092488.40085.15","article-title":"Blood pressure reduction and secondary prevention of stroke and other vascular events: A systematic review","volume":"34","author":"Rashid","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.hipert.2018.05.003_bib0355","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2174\/156802609789869592","article-title":"Blood pressure as a therapeutic target in stroke","volume":"9","author":"Armario","year":"2009","journal-title":"Curr Topics Med Chemistry"},{"key":"10.1016\/j.hipert.2018.05.003_bib0360","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jash.2014.05.002","article-title":"Lowering blood pressure to prevent stroke recurrence: A systematic review of long-term randomized trials","volume":"8","author":"Feldstein","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.hipert.2018.05.003_bib0365","first-page":"287","article-title":"Prevenci\u00f3n secundaria del ictus isqu\u00e9mico no cardiometab\u00f3lico","volume":"27","author":"Armario","year":"2015","journal-title":"Clin Investig Arterioscl"},{"key":"10.1016\/j.hipert.2018.05.003_bib0370","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WCO.0000000000000407","article-title":"Optimal blood pressure target in stroke prevention","volume":"30","author":"Yannoutsos","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.hipert.2018.05.003_bib0375","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.hipert.2018.05.003_bib0380","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.115.06480","article-title":"Achieved blood pressure and outcomes in the Secondary Prevention of Small Subcortical Strokes Trial","volume":"67","author":"Odden","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.hipert.2018.05.003_bib0385","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/CIRCULATIONAHA.115.019657","article-title":"Effect of intensive versus usual blood pressure control on kidney function among individuals with prior lacunar stroke. A post hoc analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) randomized trial","volume":"133","author":"Peralta","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hipert.2018.05.003_bib0390","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.hjh.0000226212.34055.86","article-title":"Lower target blood pressure are safe and effective for the prevention of recurrent stroke: The PROGRESS trial","volume":"24","author":"Arima","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.hipert.2018.05.003_bib0395","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2011.1650","article-title":"Level of systolic blood pressure within the normal range and risk of recurrent stroke","volume":"306","author":"Ovbiagele","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.hipert.2018.05.003_bib0400","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/HYPERTENSIONAHA.117.10087","article-title":"Treating visit-to-visit blood pressure variability to improve prognosis. Is amlodipine the drug of choice?","volume":"70","author":"Kollias","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.hipert.2018.05.003_bib0405","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2018.05.003_bib0410","doi-asserted-by":"crossref","unstructured":"ACCORD Study Group, Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575-1585.","DOI":"10.1056\/NEJMoa1001286"},{"key":"10.1016\/j.hipert.2018.05.003_bib0415","first-page":"e284","article-title":"Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association\/American Stroke Association","volume":"48","author":"Gorelik","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.hipert.2018.05.003_bib0420","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.hipert.2018.05.003_bib0425","unstructured":"National Institute for Health and Clinical Excellence. Hypertension: clinical management of primary hypertension in adults (update) (Clinical guideline 127.) 2011. [consultado 23 May 2018]. Disponible en: http:\/\/guidance. nice.org.uk\/CG127"},{"key":"10.1016\/j.hipert.2018.05.003_bib0430","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint NationalCommittee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.hipert.2018.05.003_bib0435","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.STR.0000166048.35740.a9","article-title":"Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention. Principal results of a prospective randomized controlled study (MOSES)","volume":"36","author":"Schrader","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.hipert.2018.05.003_bib0440","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183718300643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183718300643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:15:06Z","timestamp":1784596506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1889183718300643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1889183718300643"],"URL":"https:\/\/doi.org\/10.1016\/j.hipert.2018.05.003","relation":{},"ISSN":["1889-1837"],"issn-type":[{"value":"1889-1837","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recomendaciones sobre el tratamiento de la hipertensi\u00f3n arterial en la prevenci\u00f3n secundaria del ictus isqu\u00e9mico","name":"articletitle","label":"Article Title"},{"value":"Hipertensi\u00f3n y Riesgo Vascular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hipert.2018.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SEH-LELHA. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}